Evidence map›Paper›PMID 23565249›Full record

ArticlePloS one2013

The Drosophila over compensating males gene genetically inhibits dosage compensation in males.

Chiat Koo Lim, Richard L Kelley

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chiat Koo LimProgram in Developmental Biology, Baylor College of Medicine, Houston, TX, USA. leonlimck@bics.bwh.harvard.edu
Richard L Kelley
Baylor College of Medicine · US

Funding

Noncoding RNAs and Chromatin StructureR01GM071538 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI KELLEY, RICHARD L · 2004 to 2007
$1.1M
NIGMS NIH HHS 5R01GM071538NIGMS NIH HHS R01 GM071538
6 · The paper itself

Abstract

Male Drosophila are monosomic for the X chromosome, but survive due to dosage compensation. They use the Male Specific Lethal (MSL) complex composed of noncoding roX RNA and histone modifying enzymes to hypertranscribe most genes along the X ∼1.6-1.8 fold relative to each female allele. It is not known how the MSL complex achieves this precise adjustment to a large and diverse set of target genes. We carried out a genetic screen searching for novel factors that regulate dosage compensation in flies. This strategy generated thirty alleles in a previously uncharacterized gene, over compensating males (ocm) that antagonizes some aspect of MSL activity. The mutations were initially recovered because they derepressed an MSL-dependent eye color reporter. Null ocm mutations are lethal to both sexes early in development revealing an essential function. Combinations of hypomorphic ocm alleles display a male specific lethality similar to mutations in the classic msl genes, but ocm males die due to excessive, rather than lack of dosage compensation. Males that die due to very low MSL activity can be partially rescued by ocm mutations. Likewise, males that would die from ocm mutations can be rescued by reducing the dose of various msl and roX genes. ocm encodes a large nuclear protein that shares a novel cysteine rich motif with known transcription factors.

Indexed as

AnimalsDNA-Binding ProteinsDosage Compensation, GeneticDrosophila ProteinsFemaleMaleNuclear ProteinsTranscription FactorsX ChromosomeDNA-Binding ProteinsDrosophila Proteinsmsl-1 protein, Drosophilamsl-2 protein, Drosophilamsl-3 protein, DrosophilaNuclear ProteinsroX1 protein, DrosophilaTranscription Factors

Identifiers

PMID23565249
PMCPMC3615101
OpenAlexW2000264942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.